Imagine wearing a heavy rubber boot all day that traps sweat and causes blisters; that is what many amputees experience with their prosthetic sockets. This solution acts like a high-tech sponge and vent system for the limb. It pulls sweat away from the skin and lets the area breathe, making the prosthetic feel cooler and safer to wear for long hours.
Over half of prosthetic users suffer from heat and moisture buildup, leading to skin breakdown and infections. Current liners fail to ventilate the stump, limiting the amount of time a user can comfortably wear their prosthesis.
A three-layer prosthetic liner consisting of a breathable compression sock, a super-absorbent middle layer, and a protective outer load-transmitting layer.
If you are a prosthetics manufacturer dealing with high rates of patient skin irritation—this project developed a three-layer liner that reduces relative humidity around the stump by half. This prevents chafing and blisters, allowing users to wear devices for longer periods.
If you are a textile producer dealing with the challenge of moisture management under pressure—this project developed a washable super-absorbent material that can absorb up to 1000% of its weight in water. This technology can be integrated into specialized medical garments.
If you are a clinic dealing with patients who suffer from prosthetic-related infections—this project developed a ventilating liner system. By reducing humidity by half, it lowers the risk of sores and infections for the 53% of users who complain about thermal discomfort.
Based on available project data, a commercial strategy for the private label has been developed, but specific pricing figures are not disclosed.
The project has focused on fine-tuning the technical solution into a finalized product and defining the complete assortment, suggesting a move toward industrialization.
During the progress year, two new possibilities for IP have been identified, indicating expanding patent potential.
The company has developed a regulatory strategy to ensure the private label meets necessary medical standards.
The project period runs from 2023-01-01 to 2025-12-31, with current efforts focused on freezing the design and solving remaining technical issues.
The project is led by a single Swedish SME, C Lindhextend Aktiebolag, with a 100% industry ratio. This lean structure allows for rapid prototyping and direct control over the commercial strategy, though it lacks the diverse academic or research partner base typically seen in larger consortia.
Contact C Lindhextend Aktiebolag via their official website for licensing or partnership inquiries.
Contact us to explore partnership opportunities with this Swedish medical textile innovator.
